Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

24.94B

Market cap24.94B

Price-Earnings ratio

28.80

Price-Earnings ratio28.80

Dividend yield

—

Dividend yield—

Average volume

1.63M

Average volume1.63M

High today

$165.29

High today$165.29

Low today

$158.02

Low today$158.02

Open price

$159.96

Open price$159.96

Volume

787.07K

Volume787.07K

52 Week high

$165.29

52 Week high$165.29

52 Week low

$78.79

52 Week low$78.79

Stock Snapshot

With a market cap of 24.94B, Illumina(ILMN) trades at $164.87. The stock has a price-to-earnings ratio of 28.80.

As of 2026-05-29, Illumina(ILMN) stock has fluctuated between $158.02 and $165.29. The current price stands at $164.87, placing the stock +4.3% above today's low and -0.3% off the high.

Illumina(ILMN) shares are trading with a volume of 787.07K, against a daily average of 1.63M.

In the last year, Illumina(ILMN) shares hit a 52-week high of $165.29 and a 52-week low of $78.79.

ILMN News

Simply Wall St 10h

Assessing Illumina Valuation After Its New MRD Research Solution Expands Oncology Offering

Advertisement Why Illumina’s new MRD kit matters for the stock Illumina (ILMN) has drawn fresh attention after launching a whole genome based molecular residu...

TipRanks 1d

Illumina announces new complete solution for MRD research

Illumina (ILMN) announced a new complete solution for molecular residual disease research based on whole-genome sequencing. As a distributed kit, it will enable...

TipRanks 3d

Illumina Shareholders Back Board, Auditor and Executive Pay

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

52%

of 23 ratings

Buy

52.2%

Hold

30.4%

Sell

17.4%

More ILMN News

Simply Wall St 4d

How Adding Diagnostics Veteran David King To The Board At Illumina Has Changed Its Investment Story

Illumina, Inc. has added former Labcorp Executive Chairman and CEO David P. King to its Board of Directors, following the May 21, 2026 annual shareholder meetin...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.